Mikkel G. Terp
Odense, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Stable global repertoire architecture masks short-term clonal remodeling in intratumoral TCR repertoires.
Journal: Frontiers in immunology
Published: February 28, 2026
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA-mutant breast cancer.
Journal: Science translational medicine
Published: December 17, 2025
Pulmonary surfactant protein D reduces lung cancer progression associated with decreased IL-4/STAT6 signaling.
Journal: NPJ precision oncology
Published: April 23, 2025
Systematic design of DMBT1-derived peptides correlating physicochemical properties and sequence motifs with siRNA delivery and efficacy in cancer therapy.
Journal: EBioMedicine
Published: April 22, 2025
Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation.
Journal: Cardiovascular research
Published: January 19, 2025
Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 03, 2024
Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM26.
Journal: Nuclear medicine and biology
Published: June 11, 2024
SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer.
Journal: Cancer research
Published: May 17, 2024
The adaptor protein Miro1 modulates horizontal transfer of mitochondria in mouse melanoma models.
Journal: Cell reports
Published: January 22, 2024
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.
Journal: Molecular cancer
Published: June 01, 2023
Last Updated: 09/26/2026